CLINICAL_TRIALS
trial_result
· 2014-12-30
Clinical Trial Update: Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib [Phase 4]
Summary
A Phase IV randomized trial evaluating sustained sorafenib treatment in renal cell carcinoma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Carcinoma, Renal Cell | Phase 4 | Status: TERMINATED